10 analysts have expressed a variety of opinions on Globe Life GL over the past quarter, offering a diverse set of opinions from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 0 | 4 | 6 | 0 | 0 |
| Last 30D | 0 | 1 | 1 | 0 | 0 |
| 1M Ago | 0 | 2 | 3 | 0 | 0 |
| 2M Ago | 0 | 0 | 1 | 0 | 0 |
| 3M Ago | 0 | 1 | 1 | 0 | 0 |
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $116.8, with a high estimate of $136.00 and a low estimate of $75.00. Highlighting a 11.18% decrease, the current average has fallen from the previous average price target of $131.50.
Breaking Down Analyst Ratings: A Detailed Examination
The perception of Globe Life by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Mark Hughes | Truist Securities | Lowers | Hold | $80.00 | $125.00 |
| Ryan Krueger | Keefe, Bruyette & Woods | Lowers | Outperform | $110.00 | $130.00 |
| Mark Hughes | Truist Securities | Maintains | Hold | $125.00 | $125.00 |
| Thomas Gallagher | Evercore ISI Group | Lowers | In-Line | $75.00 | $125.00 |
| Elyse Greenspan | Wells Fargo | Lowers | Overweight | $132.00 | $146.00 |
| Ryan Krueger | Keefe, Bruyette & Woods | Lowers | Market Perform | $130.00 | $135.00 |
| John Barnidge | Piper Sandler | Lowers | Overweight | $130.00 | $143.00 |
| Thomas Gallagher | Evercore ISI Group | Lowers | In-Line | $125.00 | $138.00 |
| Mark Hughes | Truist Securities | Raises | Hold | $125.00 | $115.00 |
| Jimmy Bhullar | JP Morgan | Raises | Overweight | $136.00 | $133.00 |
Key Insights:
- Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Globe Life. This insight gives a snapshot of analysts' perspectives on the current state of the company.
- Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Globe Life compared to the broader market.
- Price Targets: Understanding forecasts, analysts offer estimates for Globe Life's future value. Examining the current and prior targets provides insight into analysts' changing expectations.
For valuable insights into Globe Life's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
Stay up to date on Globe Life analyst ratings.
About Globe Life
Globe Life Inc is an insurance holding company. It provides a variety of life and supplemental health insurance products and annuities to a broad base of customers. The company's core operations are organized into four reportable segments: life insurance, supplemental health insurance, annuities, and investments. Investment activities, conducted by the investment segment, focus on seeking investments with a yield and term appropriate to support the insurance product obligations. These investments generally consist of fixed maturities and, over the long term, the expected yields are considered when setting insurance premium rates and product profitability expectations.
Key Indicators: Globe Life's Financial Health
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Globe Life displayed positive results in 3 months. As of 31 December, 2023, the company achieved a solid revenue growth rate of approximately 6.04%. This indicates a notable increase in the company's top-line earnings. When compared to others in the Financials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 19.41%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 6.03%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 1.01%, the company showcases effective utilization of assets.
Debt Management: With a below-average debt-to-equity ratio of 0.47, Globe Life adopts a prudent financial strategy, indicating a balanced approach to debt management.
Understanding the Relevance of Analyst Ratings
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
